Roche drug shows promise in early Alzheimer’s
Wednesday, October 12th, 2011(Reuters) – An experimental drug being developed by Roche Holding AG removed amyloid plaques from the brains of Alzheimer’s disease patients in a small early-stage study, according to data published in the Archives of Neurology, the Swiss drugmaker said on Monday.
Read the original here:
... continue reading